• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/7

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

7 Cards in this Set

  • Front
  • Back
Cirrhosis

Epidemiology
12th most common cause of death (USA)
Most common of liver-related deaths
Cirrhosis

Aetiologies
Common:
Alcohol abuse,
viral hepatitis,
non-alcoholic steatohepatitis (NASH)

Less common:
Biliary disease,
metabolic (Haemochromatosis, Wilsons, a1AT),
cryptogenic (15%)
Cirrhosis

Aetiologies (Mneumonic)
A: Autoimmune
B: Biliary diseases, Hepatitis B
C: Cryptogenic, HCV
D: Drugs, HDV
E: Ethanol
F: Fat
G: Genetic (Wilson’s)
H: Haemochromatosis
Cirrhosis

3 main morphological features
1) Bridging Fibrous septa:
- Delicate bands or broad scars linking portal tracts with one
another and portal tracts with terminal hepatic veins.
- Fibrosis is key feature of progressive liver damage

2) Parenchymal nodules:
Containing hepatocytes encircled by fibrosis,
- With diameters from <0.3cm to several centimetres.
- Nodularity results from cycles of hepatocyte regeneration and scarring

3) Disruption of architecture of entire liver:
- Parenchymal injury and consequent fibrosis are diffuse, extending throughout liver.

*Note: focal injury without scarring does not constitute cirrhosis, nor does diffuse nodular transformation without fibrosis.
i.e. Both nodules and fibrosis must be present.
Cirrhosis

Mechanism

Tip: 3 central pathogenic processes
Central pathogenic processes:
1. Death of heptocytes
2. ECM deposition
3. Vascular reorganisation

Liver parenchymal damage and scarring
-> Vascular architecture disrupted
-> New vascular arrangements occcur in fibrotic septa
= Shunting of blood from parenchyma

Predominant mechanism of fibrosis:
Proliferation of hepatic stellate cells
+ Activation into highly fibrogenic cells (myofibroblasts)
Process mediated by cytokines (from Kupffer cells, lymphocytes, etc.)

Surviving hepatocytes
-> Confined by fibrous septa
-> Stimulated to regenerate + proliferate as spherical nodules within

NET OUTCOME:
- Fibrotic, nodular liver
- Blood delivery to hepatocytes is severely compromised
- Delivery of substances into plasma severely compromised as well
Cirrhosis: Clinical features
40% asymptomatic until late in course of disease.

Presentation = non-specific:
anorexia,
weight loss,
weakness,
liver failure signs (late disease)

Incipent/overt hepatic failure if there is increased metabolic load
(e.g. systemic infection, GIT hemorrhage)

Pulmonary:
Severely impaired oxygenation (hepatopulmonary syndrome)
Cirrhosis: 3 main causes of death
1) Progressive liver failure
2) Complication related to portal hypertension
3) Development of hepatocellular carcinoma